Showing results (111-120 of 171) with videos related to

Sort By:
Pageof 18
Laboratory Investigation; a Journal of Technical Methods and Pathology|April 11, 2023
Aryl Hydrocarbon Receptor Activation Coordinates Mouse Small Intestinal Epithelial Cell ProgrammingXiaoliang Zhou, Debopriya Chakraborty, Iain A Murray, et al.
RSC Advances|April 24, 2025
Targeting VEGFR-2 in breast cancer: synthesis and in silico and in vitro characterization of quinoxaline-based inhibitorsIbrahim H Eissa, Alaa Elwan, Mustafa A Al-Qadhi, et al.
Future Medicinal Chemistry|May 19, 2026
New chromene derivatives as promising VEGFR-2 inhibitors: combined experimental, DFT, and molecular dynamics approachesEslam B Elkaeed, Hazem Elkady, Walid E Elgammal, et al.
Spine|February 1, 2014
Incidence and clinical significance of vascular encroachment resulting from freehand placement of pedicle screws in the thoracic and lumbar spine: analysis of 6816 consecutive screwsScott L Parker, Anubhav G Amin, David Santiago-Dieppa, et al.
Drug Development Research|May 3, 2026
Structure-Guided Design and Mechanistic Elucidation of New Chromene Derivatives as Selective Vascular Endothelial Growth Factor Receptor-2 Inhibitors With Potent Anticancer ActivityHazem Elkady, Walid E Elgammal, Ibrahim H Eissa, et al.
Antimicrobial Agents and Chemotherapy|January 20, 2000
Molecular genetic analysis of nucleotide polymorphisms associated with ethambutol resistance in human isolates of Mycobacterium tuberculosisS V Ramaswamy, A G Amin, S Göksel, et al.
Hepatology Communications|October 5, 2022
Glycine-β-muricholic acid antagonizes the intestinal farnesoid X receptor-ceramide axis and ameliorates NASH in miceJie Jiang, Yuandi Ma, Yameng Liu, et al.
Future Medicinal Chemistry|June 16, 2026
Thiazolidin-based dual Aurora kinase inhibitors with potent anticancer activityWalid E Elgammal, Hazem Elkady, Aisha A Alsfouk, et al.
Carcinogenesis|October 1, 1995
Enhancement of esophageal carcinogenesis in male F344 rats by dietary phenylhexyl isothiocyanateG D Stoner, J C Siglin, M A Morse, et al.
Communications Biology|October 13, 2021
Monoclonal antibodies from humans with Mycobacterium tuberculosis exposure or latent infection recognize distinct arabinomannan epitopesElise Ishida, Devin T Corrigan, Ryan J Malonis, et al.
Pageof 18